Dr Ricky Tirtakusuma Dr Katarzyna Szoltysek Professor Vasily Grinev Dr Sirintra Nakjang Dr Daniel Williamson et al. | Epigenetic regulator genes direct lineage switching in MLL/AF4 leukemia | 2022 |
|
Dr Wei-Yu Lin Dr Sarah Fordham Dr Nicola Sunter Dr Claire Elstob Dr Thahira Rahman et al. | Genome-wide association study identifies risk loci for progressive chronic lymphocytic leukemia | 2021 |
|
Dr Sarah Fordham Dr Helen Blair Dr Claire Elstob Professor Ruth Plummer Dr Yvette Drew et al. | Inhibition of ATR acutely sensitises acute myeloid leukemia cells to nucleoside analogs that target ribonucleotide reductase | 2018 |
|
Dr Aiste McCormick Gavin Cuthbert Dr Rachel O'Donnell Dr Brian Wilson Huw Thomas et al. | Functional characterisation of a novel ovarian cancer cell line, NUOC-1 | 2017 |
|
Dr Victoria Forster Mohammed Nahari Dr Natalia Martinez Soria Amy Bradburn Dr Sarah Fordham et al. | The leukemia-associated RUNX1/ETO oncoprotein confers a mutator phenotype | 2016 |
|
Dr Mark Wade Dr Nicola Sunter Dr Sarah Fordham Anna Long Dino Mašić et al. | c-MYC is a radiosensitive locus in human breast cells | 2015 |
|
Fiona Middleton Dr Miranda Patterson Dr Claire Elstob Dr Sarah Fordham Dr Ashleigh Herriott et al. | Common cancer-associated imbalances in the DNA damage response confer sensitivity to single agent ATR inhibition | 2015 |
|
Dr Sarah Fordham Mike Cole Professor Julie Irving Professor James Allan
| Cytarabine preferentially induces mutation at specific sequences in the genome which are identifiable in relapsed acute myeloid leukaemia | 2015 |
|
Dr Sarah Fordham Mike Cole Professor Julie Irving Professor James Allan
| Cytarabine leaves a mutational fingerprint in relapsing leukemia | 2014 |
|
Dr Mohammad Moad Dr Deepali Pal Dr Anastasia Hepburn Dr Stuart Williamson Laura Wilson et al. | A novel model of urinary tract differentiation, tissue regeneration, and disease: Reprogramming human prostate and bladder cells into induced pluripotent stem cells | 2013 |
|
Dr Sarah Fordham Dr Helen Marr Professor James Allan
| Searching for clarity in therapy-related myelodysplastic syndrome/acute myeloid leukemia prognostication | 2013 |
|
Dr Sarah Fordham Dr Victoria Forster Professor Graham Jackson Dr Simon Bomken Professor James Allan et al. | A functional variant in the core promoter of the CD95 cell death receptor gene predicts prognosis in acute promyelocytic leukemia | 2012 |
|
Dr Sarah Fordham Emeritus Professor Keith Scott Professor Julie Irving Professor James Allan
| Cellular Response to Cytarabine is Modulated by the DNA Mismatch Repair Pathway: Implications for Treatment of Acute Myeloid Leukemia | 2010 |
|
Dr John Anderson Dr Stephen Crosier Lynne Overman Dr Tryfonia Mainou-Fowler Dr Sarah Fordham et al. | Survivin in diffuse large B cell lymphoma: Evaluation as a prognostic marker | 2005 |
|